Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Nectar Lifescience LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532649 NSE Symbol: NECLIFE P/E (TTM) :0
ISIN Demat:INE023H01027 Div & Yield %:0 EPS (TTM) :0
Book Value (RS) :42.6340837 Market Cap (Rs Cr.):436.64 Face Value (RS) :1
    Change Company 
YearsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.650.750.820.770.75
Long Term Debt-Equity Ratio0.170.240.200.110.13
Current Ratio1.321.331.171.121.18
Fixed Assets1.221.121.231.151.76
Inventory2.792.623.092.262.79
Debtors5.854.814.694.575.51
Interest Cover Ratio1.21-0.021.320.471.28
PBIDTM (%)8.633.298.356.418.42
PBITM (%)5.47-0.105.393.006.12
PBDTM (%)4.10-1.264.260.063.66
CPM (%)3.41-0.223.790.713.44
APATM (%)0.26-3.610.83-2.711.14
ROCE (%)5.96-0.095.282.718.17
RONW (%)0.47-5.851.48-4.352.68

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)